Erratum

Quilty S, Matthews V, Baumann A, et al. Designing Housing to Reduce Overcrowding-Related Harms: Rheumatic Heart Disease as the Canary in the Coal Mine. Med J Aust 2026; https://doi.org/10.5694/mja2.70209    In this perspective article, the state listed for affiliation 4, 5 and 6 was incorrectly listed as “Northwest Territories” when it should be “Northern Territories”.

P. M. Latt, E. T. Aung, K. Maddaford, et al; DoxyAWARE Study Group. Awareness, Usage and Perceptions of Doxycycline Post‐Exposure Prophylaxis (doxyPEP) for Prevention of Sexually Transmitted Infections in Australia: Insights From a National Cross‐Sectional Survey. Medical Journal of Australia 2026; 224(4): e70180. https://onlinelibrary.wiley.com/doi/10.5694/mja2.70180. In the second paragraph of section 3.3. Uptake and Dosage Regimens, where it says ‘Only 4/323 (1.2%) took it every day (i.e., doxyPrEP), and the remainder 114/323 (35.3%) used other non-recommended regimens (3/323, 0.9%),’ it should read ‘Only 4/323 (1.2%) took it every day (i.e., doxyPrEP), and the remainder 114/323 (35.3%) used other non-recommended regimens’.

S. Yuill, C. Naidu, M. Smith, D. Bateson, M. Saville, B. Damutalau, K. Canfell. Cervical cancer elimination in Australia and the Asia Pacific: Progress and barriers. Medical Journal of Australia 2026; 224(4): e70164. https://onlinelibrary.wiley.com/doi/10.5694/mja2.70164. The affiliations for Marion Saville were out of date at the time of submission and should read: Australian Centre for the Prevention of Cervical Cancer, Melbourne, Victoria, Australia; University of Malaya, Kuala Lumpur, Malaysia.

R. Dawson, M. Pinheiro, J. Oliveira, et al. The Telephysiotherapy for Older People (TOP-UP) program for improving mobility in people receiving aged care: a hybrid type 1 effectiveness–implementation randomised controlled trial. Med J Aust 2025; 223: 205-213. https://onlinelibrary.wiley.com/doi/10.5694/mja2.70004 In Box 6, the first data row erroneously stated that the intervention had 192 participants instead of 92. The table should read as follows: BOX 6 | Six-month outcomes of the telephysiotherapy for older people (TOP-UP) trial, 1 September 2021 to 30 November 2023: falls.

K. Thapaliya, A. Sweeting, K. I. Black, A. Poprzeczny, D. Mazza, L. E. Grzeskowiak, “Incidence of GLP-1 Receptor Agonist Use by Women of Reproductive Age Attending General Practices in Australia, 2011–2022: A Retrospective Open Cohort Study,” Medical Journal of Australia 223, no. 7 (2025): 365–371, https://onlinelibrary.wiley.com/doi/10.5694/mja2.70026 In Box 4, the y-axis should read ‘Proportion (%)’, as shown below: Box 4. Proportion of women aged 18–49 years who conceived within 6months of the first prescribing of glucagon-like peptide-1 (GLP-1) receptor agonists, 2011–2022, by type 2 diabetes status.

Lodge C, Dai X, Laing IA, et al. Evidence from Australian cohort studies about asthma trajectories and transitions across the life course: a narrative review. Med J Aust 2025; 223 (10 Suppl): S24–S31. https://doi.org/10.5694/mja2.70086. In Box 3, the second data row should read as follows: Study Start year Age at start, in years (enrollees) Age at follow-up Wheeze/asthma definition Lung function assessed Biological samples Busselton Health studies33 1966 7 to > 70 (20 000) 20 to > 90 Standard asthma questions. Spirometry: forced oscillation technique (all studies) airway responsiveness (selected studies). Blood at 21 surveys that collected asthma data.

Cubitt M, Lim S. A future for the hospital-in-the-home (HITH) deteriorating patient: shifting the paradigm. Med J Aust 2025 ; 222: 168‐171. https://doi.org/10.5694/mja2.52588 In this perspective article, the author Penelope A Bryant was accidentally left off the authors list. The complete authors list should read: Mya Cubitt, Penelope Bryant, Seok Lim. Affiliations for Penelope Bryant: The Royal Children’s Hospital Melbourne, Melbourne, VIC; University of Melbourne, Melbourne, VIC; Murdoch Children’s Research Institute, Melbourne, VIC Penelope Bryant declares no conflicts of interest.

Hengel B, Guy RJ, Casey D, et al. Decentralised COVID‐19 molecular point‐of‐care testing: lessons from implementing a primary care‐based network in remote Australian communities. Med J Aust 2025 ; https://doi.org/10.5694/mja2.52589. In this perspective article, the middle initial of the seventh author was incorrect; it should read Tanya L Applegate.

Macintyre PE, Jamcotchian MA, Stevens JA. Calling time on the use of modified‐release opioids for acute pain. Med J Aust 2024; https://doi.org/10.5694/mja2.52417 Requirements for individualised opioid titration regimens The opioid prescription The initial dose range of opioid prescribed should vary according to the age of the patient (for opioid‐naïve patients) and the severity of the anticipated pain: ‣ Age is a better predictor of opioid requirements than patient weight ‣ Increasing age is associated with decreased opioid requirements and this appears to be primarily due to pharmacodynamic rather than pharmacokinetic factors; that is, increased sensitivity of the central nervous system with ageing rather than the changes in metabolism and excretion of the drug that might also be seen in older patients ‣ The initial opioid dose range prescribed should be lower in patients with moderate pain than those with severe acute pain; lower doses may also be safer where appropriate monitoring is not reliable Subsequent doses may need to be adjusted according to patient response (analgesic effectiveness and adverse effects) Prescribe an appropriate dose interval (the interval within which additional doses should not be given): ‣ In some settings (eg, where there is 24‐hour medical cover and experienced nursing staff and appropriate monitoring are available) it may be reasonable to order an IR opioid “every two hours as needed”; in other settings “every four hours as needed” may be safer Order “as needed” only and not on a regular (time‐contingent) basis; write maximum 24‐hour dose as “sedation score less than 2” Coprescription of naloxone is suggested The IR opioid should be used for the shortest time possible and in decreasing doses over a short time. Deprescribing starts in hospital and requires involvement of nurses, doctors, ward pharmacists and the patient: ‣ This requires regular patient review ‣ The opioid prescription may need to be rewritten to allow for or assist with decreasing opioid dose trajectories, sometimes on a daily basis Assessment of analgesic effectiveness Unidimensional pain scores are commonly used in the acute pain setting to determine analgesic effectiveness and guide opioid titration: ‣ Do not adjust analgesic regimens, including opioid doses, based on a patient's pain scores alone ‣ Predictors of high pain scores include psychological comorbid conditions (eg, anxiety, catastrophising), pre‐existing chronic pain, and tolerance to opioids, and therefore high scores do not always mean that an opioid — or more opioid — is needed ‣ A patient's pain score trajectory (plotting a patient's pain scores over time) is a more useful indicator of patient progress and can allow identification of psychological distress, the presence of non‐opioid‐responsive pain and post‐operative/post‐trauma complications; pain score trajectories that do not decrease over the first few days are also good predictors of chronic post‐surgical pain. Patients whose pain score trajectories are not decreasing require review ‣ “Chasing” pain scores with opioids to achieve an arbitrarily defined acceptable level of pain or zero pain can lead to increases in the risk of OIVI and PPOU Include an assessment of patient function (eg, using functional activity scores). One example of a functional activity score is: A — no limitation of relevant activity due to pain (relative to baseline) B — mild limitation of activity due to pain C — unable to complete activity due to pain Recognition of OIVI Increasing sedation is a more reliable indicator of developing OIVI than a decrease in respiratory rate: ‣ Respiratory rate can remain within acceptable limits even when OIVI is severe ‣ Record sedation scores (along with pain scores and functional activity scores) at time of administration of the IR opioid and when peak effect is expected (ie, about one hour after administration of an oral IR opioid) One suggested sedation scoring system is: 0 = wide awake, 1 = easy to rouse (and can stay awake), 2 = easy to rouse but unable to remain awake, and 3 = difficult to rouse: ‣ Titrate opioids so that sedation score is always <2 Hypoxaemia may be a very late sign of hypoventilation, especially if the patient is receiving supplemental oxygen Immediate intervention is required if a patient has a sedation score of 2 or 3, regardless of the patient's respiratory rate doi: 10.5694/mja2.52417

Kapeke K, Hollonds A, Maury S. Future Healthy Countdown 2030: from passive trickle‐down to active participation for improved health and wellbeing of children, young people and future generations. Med J Aust 2024; https://doi.org/10.5694/mja2.52491 In this editorial, on page S5, the surname of the second author in reference 14 was misspelled. The correct spelling is Honisett.

Montgomery A, Honisett S, Hall T, et al. Co‐designing integrated child and family hubs for families experiencing adversity. Med J Aust 2024 ; https://doi.org/10.5694/mja2.52486 In this perspective article, on page S41, the surname of the second author was misspelled. The correct spelling is Honisett.

Robinson D, McFadyen J, Merriman E, et al. Updated recommendations for warfarin reversal in the setting of four–factor prothrombin complex concentrate. Med J Aust 2024; doi: 10.5694/mja2.52538 In this consensus statement article, the name of the fourth author has been erroneously cited as “Tan Chee Wee”. The correct spelling is “Chee Wee Tan”. ■

Gordon EH, Hubbard RE. Harming those we intend to help: hospital‐acquired complications in patients with dementia. Med J Aust 2024 ; 221: 420–421. https://doi.org/10.5694/mja2.52463. In the third paragraph, “Author” should read “Ní Chróinín.”

Macintyre PE, Jamcotchian MA, Stevens JA . Calling time on the use of modified-release opioids for acute pain. ,Med J Aust 2024; https://doi.org/10.5694/mja2.52417 In this perspective article, the first sentence in the section “Recent changes to opioid-prescribing guidelines in Australia” should read: “In 2020, regulatory changes made by the Australian Therapeutics Goods Administration were designed to decrease the risk of harm from prescription opioids”. ■ 10.5694/mja2.52534

Skinner T, Brown A, Teixeira‐Pinto A, et al. Sensitivity and specificity of Aboriginal‐developed items to supplement the adapted PHQ‐9 screening measure for depression: results from the Getting it Right study. Med J Aust 2024; https://doi.org/10.5694/mja2.52406

Baumgart SWLW, English S, Sebastian T, et al. Group A streptococcal colitis: an under‐recognised entity? Med J Aust 2024 https://doi.org/10.5694/mja2.52382 In this medical education article, in the first sentence of the Discussion section, where it says “… an aerobic, β‐haemolytic, gram‐positive coccus”, it should say “… a facultative anaerobic, β‐haemolytic, gram‐positive coccus”.

Marchant, JM, Chang, AB, Kennedy, E, et al. Cough in Children and Adults: Diagnosis, Assessment and Management (CICADA). Summary of an updated position statement on chronic cough in Australia. Med J Aust 2023; https://doi.org/10.5694/mja2.52157 In this position statement summary, the name of one author was misspelled; it should read Naomi Fitzakerley.

Brown KGM, Ansari N, Solomon MJ. Contemporary management of advanced colorectal cancer: the Australian experience. Med J Aust 2024 ; https://doi.org/10.5694/mja2.52218 In this Perspective, the Provenance line should read: “Commissioned; externally peer reviewed.”

Tunnicliffe DJ, Bateman S, Arnold‐Chamney M, et al. Recommendations for culturally safe clinical kidney care for First Nations Australians: a guideline summary. Med J Aust 2023; https://doi.org/10.5694/mja2.52114 This is an erratum for Recommendations for culturally safe clinical kidney care for First Nations Australians: a guideline summary. In this Guideline summary, the author Ro‐Anne Stirling‐Kelly was accidentally removed from the authors list. The complete list should read: David J Tunnicliffe1,2 Samantha Bateman3,4 Melissa Arnold‐Chamney3 Karen M Dwyer5 Martin Howell1,2 Azaria Gebadi1,2 Shilpa Jesudason6 Janet Kelly3 Kelly Lambert7,8 Sandawan William Majoni9,10 Dora Oliva11 Kelli J Owen3,12 Odette Pearson13,14 Elizabeth Rix3,15 Ieyesha Roberts1,2 Ro‐Anne Stirling‐Kelly1,2,16 Kimberly Taylor17 Gary A Wittert3,18 Katherine Widders1,2 Adela Yip1,2 Jonathan Craig10 Richard K Phoon1,19 1 University of Sydney, Sydney, NSW. 2 Centre for Kidney Research, Children's Hospital at Westmead, Sydney, NSW. 3 University of Adelaide, Adelaide, SA. 4 Central and Northern Adelaide Renal and Transplantation Services, Central Adelaide Local Health Network, Adelaide, SA. 5 Deakin University, Geelong, VIC. 6 Kidney Health Australia, Adelaide, SA. 7 University of Wollongong, Wollongong, NSW. 8 Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW. 9 Royal Darwin Hospital, Darwin, NT. 10 Flinders University, Adelaide, SA. 11 Drug and Alcohol Services, South Australia Health, Adelaide, SA. 12 Central and Northern Adelaide Renal and Transplantation, Royal Adelaide Hospital, Adelaide, SA. 13 Wardliparingga Aboriginal Health Equity, South Australian Health and Medical Research Institute, Adelaide, SA. 14 Cancer Research Institute, University of South Australia, Adelaide, SA. 15 Southern Cross University, Lismore, NSW. 16 NSW Health Mid‐North Coast Local Health District, Sydney, NSW. 17 Aboriginal Communities and Families Health Research Alliance, South Australian Health and Medical Research Institute, Adelaide, SA. 18 Royal Adelaide Hospital, Adelaide, SA. 19 Westmead Hospital, Sydney, NSW. https://doi.org/10.5694/mja2.52243

Black KI, Dorney E, Hall JA, et al. Using a validated instrument to assess pregnancy planning and preconception care at antenatal booking visits: a retrospective cohort study. Med J Aust 2023; 219: 366–370. https://doi.org/10.5694/mja2.52109. In the Results section of the Abstract and the third paragraph of the Results section, “59.1%” should read “54.1%”. doi: 10.5694/mja2.52155

Hla TK, Cannon JW, Bowen AC, Wyber R. Getting to grips with invasive group A streptococcal infection surveillance in Australia: are we experiencing an epidemic? Med J Aust 2023; 219 (6): 242‐245. https://doi.org/10.5694/mja2.52056. In this article, the final sentence under the heading “Inequitable epidemics” should read: “Although Indigenous status is not available in the publicly accessible National Notifiable Disease Surveillance System dataset, it is a core field and there is capacity for states and territories to report this information, to assess progress of this inequitable epidemic across Australia.”

Choi PYI, Merriman E, Bennett A, et al. Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand. Med J Aust 2022; 216: 43‐52. https://doi.org/10.5694/mja2.51284 In this Consensus statement article, the affiliations for Chee Wee Tan should be: “Royal Adelaide Hospital, Adelaide, SA; SA Pathology, Adelaide, SA; Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ), Melbourne, VIC”.